News 07.03.2025 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 06, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics ("Molecular Partners" or the "Company"), today announced its...
News 18.02.2025 Schlieren (Zurich), February 17, 2025 – LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the first participants have been vaccinated in a Phase 1 controlled study of its multivalent vaccine candidate, LBT-SA7. The candidate is designed to prevent skin and...
News 12.02.2025 Switzerland – 12 February 2025 – CUTISS AG, a life sciences company at the forefront of tissue engineering therapy and regenerative medicine, announced positive long-term efficacy and safety readout in the Phase 2 clinical trials of denovoSkin™ in reconstructive surgery as well as in burns treatment. The data reaffirm the role of...
News 06.02.2025 Schlieren-based medical device company Hemotune AG has received dual certification for its blood purification process. According to a press release, the company has received ISO 13485:2016 certification for both sterile and non-sterile medical devices and nanoparticles for blood purification. ISO 13485 is the internationally recognized standard for quality management systems in...
News 03.02.2025 Photonic Integrated Circuits (PICs) are rapidly transforming industries such as telecom, AI, datacom, and space—just as silicon chips revolutionized computing decades ago. However, the industry faces a major bottleneck: conventional semiconductor-based PICs have reached their performance limits, struggling to keep up with growing demands for speed and energy efficiency. The...